Customisable System for Biopharmaceutical Manufacturing Launched

Merck has launched its Bio4C™ Orchestrator Software, which allows users to monitor multiple unit operations remotely from a centralised dashboard.

The new software optimises processes, improves quality and reduces time to market. Merck’s Bio4C™ Orchestrator Software is a key component of the company’s Bio4C™ Software Suite, a first-of-its-kind digital ecosystem that provides monitoring, control and data insights on a process and plant level.

Today’s bioprocessing production environments are often islands of automation, consisting of independently functioning, standalone unit operations. Bioprocess scientists spend significant time moving from skid to skid logging in, loading recipes, creating reports and managing alarms. This disconnected approach is an inefficient and time-consuming way to monitor and visualise bioprocesses.

Merck’s Bio4C™ Orchestrator Software connects individual unit operations to a centralised platform for unified visibility and monitoring of regulatory compliant biomanufacturing systems and processes. This browser-based software solution provides remote access to systems, recipes, reports, user accounts and alarms from a holistic process dashboard.

Unlike currently available software systems that were designed for other industries and retrofitted for biopharma, the Bio4C™ Orchestrator Software is designed specifically for biopharmaceutical manufacturing by bioprocessing industry experts. The software allows for a seamless and customised implementation in months - not years - at a fraction of the cost of other systems. Built for pharma from the ground up, the solution’s scalable, modular architecture grows and adapts as manufacturing and facilities change and evolve.

Merck will launch additional Bio4C™ Software Suite products in 2021.

More information online